These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4581246)

  • 1. Some initial animal and human pharmacological studies with benapryzine (BRL 1288).
    Brown DM; Hughes BO; Marsden CD; Meadows JC; Spicer B
    Br J Pharmacol; 1973 Mar; 47(3):476-86. PubMed ID: 4581246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of anti-Parkinson drugs on cortical neurones.
    Clarke G; Davies J
    Br J Pharmacol; 1973 Mar; 47(3):465-75. PubMed ID: 4730827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crossover clinical trial of benapryzine and trihexyphenidyl in Parkinsonian patients.
    Lamid S; Jenkins RB
    J Clin Pharmacol; 1975; 15(8-9):622-6. PubMed ID: 1097479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings: Iontophoretic study of the central anticholinergic properties of BRL 1288.
    Clarke G; Davies J; Straughan DW
    Br J Pharmacol; 1972 Feb; 44(2):344P-345P. PubMed ID: 4668612
    [No Abstract]   [Full Text] [Related]  

  • 5. Stereospecificity of oxotremorine antagonists.
    Dahlbom R; Lindquist A; Lindgren S; Svensson U; Ringdahl B; Blair MR
    Experientia; 1974 Oct; 30(10):1165-7. PubMed ID: 4435124
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo and in vitro studies on the antimuscarinic activity of some amino esters of benzilic acid.
    Rehavi M; Yaavetz B; Kloog Y; Maayani S; Sokolovsky M
    Biochem Pharmacol; 1978; 27(8):1117-24. PubMed ID: 697913
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and pharmacological properties of 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-1,2-dialkylpyrrolidine derivatives.
    Umio S; Hitomi M; Nojima H; Kumadaki N; Ueda I; Kanaya T; Deguchi Y
    J Med Chem; 1972 Sep; 15(9):891-4. PubMed ID: 4403249
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of benapryzine in psychotic patients treated with phenothiazines.
    Bartlett P; Forrest A
    Curr Med Res Opin; 1974; 2(6):313-8. PubMed ID: 4155663
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of benapyrzine, a new antiparkinson drug, on dopamine uptake into corpus striatum.
    Palfreyman MG; Palfreyman ES; Clark MS
    Eur J Pharmacol; 1974 Oct; 28(2):379-83. PubMed ID: 4418659
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action spectra of 3 anticholinergic drugs with preferential central activity (2 phenyl-2-isobutyl) ethyl pyrrolidone (1067 CERM), 2(ethyl n-propyl-amino ethyl alpha, alpha-diphenylglycolate (AP 1288) and dimethylamino-9-benziloxybicyclo (3,3,1)nonane (N1199)].
    Barthelemy C; Tremblay E; Frances H; Jacob J
    Therapie; 1972; 27(2):369-79. PubMed ID: 5084678
    [No Abstract]   [Full Text] [Related]  

  • 11. The peripheral and central actions of some anticholinergic substances.
    Brimblecombe RW; Green DM
    Int J Neuropharmacol; 1968 Jan; 7(1):15-21. PubMed ID: 5639303
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anticholinergic effects depending on the chemical constitution of a series of tertiary and quaternary propylamine derivatives].
    Ehrhart G; Härtfelder G; Schmitt K
    Arzneimittelforschung; 1970 Aug; 20(8):1094-6. PubMed ID: 5536510
    [No Abstract]   [Full Text] [Related]  

  • 13. The central and peripheral activities of anti-acetylcholine drugs. Some concepts of practical relevance.
    Inch TD; Green DM; Thompson PB
    J Pharm Pharmacol; 1973 May; 25(5):359-70. PubMed ID: 4146390
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of anti-Parkinsonian drugs on haloperidol-induced inhibition of the conditioned-avoidance response in rats.
    Davies JA; Jackson B; Redfern PH
    Neuropharmacology; 1973 Aug; 12(8):735-40. PubMed ID: 4746439
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholinolytic activity of 3-hydroxyquinuclidyl-1-phenyl-1-cyclohexyl-1-carboxylate hydrochloride (ANC-821).
    Jedrych Z
    Pol J Pharmacol Pharm; 1983; 35(2):103-7. PubMed ID: 6688667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological studies on 2- and 4-pyridylethylamides of acetyltropic acid (PAT-2 and PAT-4).
    Widy E
    Pol J Pharmacol Pharm; 1975; 27(2):139-52. PubMed ID: 168562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacology of the bronchospasmolytic oxitropium bromide].
    Bauer VR
    Arzneimittelforschung; 1985; 35(1A):435-40. PubMed ID: 4039183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anticholinergic properties of 1-Adamant-1-yl-1-phenyl-3-N-pyrrolidino-1-propanol hydrochloride.
    Cashin CH; Hotten TM; Szinai SS
    J Med Chem; 1972 Aug; 15(8):853-4. PubMed ID: 5044303
    [No Abstract]   [Full Text] [Related]  

  • 19. The production of an alternative laboratory model of the Parkinson syndrome using a new benzylimidoylurea derivative LON 954.
    Coward DM; Doggett NS
    Psychopharmacology (Berl); 1977 Apr; 52(2):165-71. PubMed ID: 407600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of aging on the responsiveness of the cholinergic receptor of the longitudinal muscle of guinea-pig isolated ileum.
    Tsai CS; Ochillo RF
    Res Commun Chem Pathol Pharmacol; 1987 Feb; 55(2):275-8. PubMed ID: 3823613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.